Navigation Links
Takeda Responds to Judgment in Diabetes Drug Case
Date:9/3/2014

ive companies currently market oral diabetes, insomnia, rheumatology, and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for metabolic and cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.takeda.us.

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to, (1) the economic circumstances surrounding Takeda's business, including general economic conditions in Japan, the United States and worldwide; (2) competitive pressures and developments; (3) applicable laws and regulations; (4) the success or failure of product development programs; (5) actions of regulatory authorities and the timing thereof; (6) changes in exchange rates; (7) claims or concerns
'/>"/>

SOURCE Takeda Pharmaceuticals U.S.A., Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
2. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
3. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
4. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
5. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
6. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
7. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
8. Takeda and Resolve Therapeutics Enter Autoimmune Partnership
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Takeda presenta la richiesta di autorizzazione allimmissione in commercio nellUnione Europea per Vedolizumab nella colite ulcerosa moderata-grave e nella malattia di Crohn
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August 11, ... Meridien in New York . A ... www.meipharma.com . A replay will be available approximately one hour ...
(Date:8/4/2015)... Pharma Ltd. (the "Company") (NASDAQ: NTEC ), a ... on its proprietary Accordion Pill platform technology, today announced ... the United States of 5,025,000 of ... of $6.00 per ordinary share, before underwriting discounts and ... by the Company.  In addition, the Company has granted ...
(Date:8/4/2015)... Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: ... of the largest network of radiotherapy and diagnostic imaging centers ... release its financial results for the second quarter of 2015 ... Management will hold a conference call to discuss the results ... 2015 (8:00 p.m. in Beijing / ...
Breaking Medicine Technology:MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2
... 26, 2011 Science, public health, and ... in this document is designed for credentialed journalists. Release dates ... 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... regulatory or enforcement actions due to legal limitations. ...
... 26, 2011 Pearl Therapeutics Inc. presented ... demonstrating that the dual bronchodilator combination product, PT003 ... to Spiriva® HandiHaler® (tiotropium bromide inhalation powder). IC is ... be predictive of improvement in exercise performance in patients ...
Cached Medicine Technology:FDA News & Notes - Week of September 26, 2011 2Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva® 2Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva® 3Pearl Therapeutics' Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva® 4
(Date:8/4/2015)... ... August 04, 2015 , ... Ryadon Inc. ... Finding reliable hardware can be difficult and troublesome for companies. Without ... together or designing a new facility, it is imperative to include only the ...
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide ... Power Products is expanding its reach in Texas. Effective July 1st of this ... North Texas generator division. With the North Texas acquisition, Worldwide Power Products ...
(Date:8/4/2015)... ... 04, 2015 , ... Many men are confused about the safety of testosterone ... up as a voice of authority for men seeking accurate information about testosterone. ... experience and expertise in the safe and effective treatment of low testosterone. In recent ...
(Date:8/4/2015)... ... August 04, 2015 , ... Increasingly, patients are ... calling a physician. In an effort to share more and better information with ... Pennsylvania to publicly share patient satisfaction ratings and comments about its doctors and ...
(Date:8/4/2015)... ... August 04, 2015 , ... Mesothelioma researchers in ... back: Retreatment may be a viable option. Surviving Mesothelioma has just posted an ... According to surgeons at the University of New South Wales, peritoneal mesothelioma ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:North Texas Acquisition Press Release 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2
... of nation,s teens; During summer months a disproportionate number of ... During this high school graduation season and at the ... the nation,s highways, a powerful coalition of medical, consumer, public ... to every member of the U.S. House of Representatives urging ...
... Year-Old USAID/State Department/Private Sector Initiative Unveils Initial Aid ... Chiles and CAFAmerica,s Saxon-Harrold Report on Progress. ... One Woman Initiative ( http://www.OneWomanInitiative.org ), a one-year-old ... significant Muslim populations, today announced its first grants, ...
... New questions and valuable answers about helping families manage their ... latest in the Heinz Family Philanthropies 10 Questions to ... the best long-term care decisions. Available today are ten questions and ... care. , , "We want to help people find reliable ...
... innovative University of Georgia graduate program in special education ... with elementary-age students with autism over the last several ... to train teachers to work with similarly challenged secondary-age ... is part of a group known as autism spectrum ...
... , Honored at Donate Life Film Festival with Inspire Award on ... 3 "E.R." may have ended, but the long-running television show ... www.DonateLifeHollywood.org ) is honoring two E.R. episodes, ... its Inspire Award from the organ and tissue donation and transplant ...
... Zebra fish release hydrogen peroxide to call white blood cells ... (HealthDay News) -- Hydrogen peroxide -- commonly used to prevent ... cells to wounded tissue, new research has found. , U.S. ... fish are injured, a spurt of hydrogen peroxide is released ...
Cached Medicine News:Health News:Medical, Insurance, Automotive and Safety Groups Call on Congress to Make This the "Last Deadly Summer for Teens" by Swiftly Passing Federal Teen Driving Safety Bill 2Health News:Medical, Insurance, Automotive and Safety Groups Call on Congress to Make This the "Last Deadly Summer for Teens" by Swiftly Passing Federal Teen Driving Safety Bill 3Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 2Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 3Health News:'One Woman Initiative' Announces First Grants to Women's Organizations in Five Nations 4Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 2Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 3Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 4Health News:New From the Heinz Family Philanthropies: 10 Questions and Valuable Answers to Help Families Manage Long-Term Care 5Health News:UGA grad program expands to prepare teachers to work with secondary students with autism 2Health News:UGA grad program expands to prepare teachers to work with secondary students with autism 3Health News:From Beginning to End, 'E.R.' Gets it Right 2Health News:Key to Wound-Healing May Be Explained in Fish Tail 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: